Loading company…
Olipharma provides contract development and manufacturing services for nucleic acid products.
Established in 2021 and based in Suzhou, China, Olipharma provides CDMO services for nucleic acid products, from drug discovery and laboratory research to process development, API production, and registration. Its services also include CMC work, analytical methods, and stability studies. The company has an R&D center in Kunshan, Suzhou, and holds quality management system certifications.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in